Why Increase Rather Than Decrease Basal Insulin?
When fasting glucose is at the upper limit of target (~100 mg/dL) on 10 units of basal insulin, you should increase the dose because this glucose level indicates inadequate basal coverage—the goal is to achieve fasting glucose in the lower target range (70-90 mg/dL or 3.9-5.0 mmol/L) to optimize HbA1c control and maximize the likelihood of reaching HbA1c <7%. 1
The Evidence-Based Rationale
Lower FPG Targets Achieve Better Outcomes
The most current ADA guidelines (2025) recommend using evidence-based titration algorithms that increase basal insulin by 2 units every 3 days until the fasting plasma glucose (FPG) goal is reached 1. The key insight is that fasting glucose at 100 mg/dL is not optimal—it's at the ceiling of acceptable control.
Research demonstrates that targeting lower FPG ranges produces superior glycemic outcomes:
- Targeting FPG 70-90 mg/dL (3.9-5.0 mmol/L) versus 80-110 mg/dL (4.4-6.1 mmol/L) resulted in significantly better HbA1c reduction (6.8% vs 7.0%, p=0.0019), with 64.3% vs 54.5% of patients achieving HbA1c <7% 2
- More ambitious FPG targets (≤90 mg/dL) improved HbA1c by an additional 0.23% and increased target achievement by up to 14.6% without increasing hypoglycemia risk 3
The 10-Unit Starting Dose is Just That—A Starting Point
The guideline explicitly states to start at 10 units per day OR 0.1-0.2 units/kg per day, then titrate upward 1. This initial dose is intentionally conservative to establish safety. At 10 units, most patients are significantly under-dosed—studies show that achieving HbA1c <7% typically requires 40-70 units/day 4.
Why Not Decrease?
Decreasing the dose would be appropriate only if:
- Hypoglycemia occurs (FPG <70 mg/dL or <3.9 mmol/L)
- The patient experiences unexplained hypoglycemic episodes 1
A fasting glucose of 100 mg/dL indicates the current dose is insufficient, not excessive. The basal insulin is failing to adequately suppress hepatic glucose production overnight.
The Titration Algorithm
Following the ADA 2025 guideline 1:
- Current situation: FPG ~100 mg/dL (5.6 mmol/L) on 10 units
- Action: Increase by 2 units every 3 days
- Target: FPG 70-100 mg/dL (ideally toward the lower end at 70-90 mg/dL for optimal HbA1c control)
- Continue titrating until target is reached without hypoglycemia
More aggressive titration (increasing 2 units every 3 days if FPG 7.1-10.0 mmol/L, or 4 units if >10.0 mmol/L) is supported by the evidence 1.
Common Pitfalls to Avoid
Therapeutic inertia is the primary pitfall—providers often fail to uptitrate insulin adequately, leaving patients with suboptimal control 1. A fasting glucose of 100 mg/dL may seem "acceptable," but it represents missed opportunity for better outcomes.
Fear of hypoglycemia is often overestimated. Studies consistently show that targeting lower FPG ranges (even 70-90 mg/dL) does not significantly increase hypoglycemia rates when titration is done systematically 2, 3.
Weight gain concerns are valid but modest—approximately 3 kg over 6 months 4—and should not prevent appropriate titration to glycemic targets that reduce long-term complications.
The Bottom Line
Your patient at FPG ~100 mg/dL on 10 units is undertreated. Increase the basal insulin dose by 2 units every 3 days, targeting FPG 70-90 mg/dL, which will maximize HbA1c reduction and target achievement without meaningfully increasing hypoglycemia risk. 1, 2, 3